Accelerating Preclinical Drug Discovery with Agentic AI

Inside Bayer’s PRINCE Multi Agent System

Discover how Bayer and Thoughtworks co-developed PRINCE, a GenAI-powered research assistant that transforms preclinical drug development by streamlining data retrieval, regulatory drafting, and metadata reannotation—cutting manual effort by 90% and enabling faster, more compliant decision-making.